CC-90010, a reversible, oral bromodomain and extra-terminal...

Annals of Oncology 2020 / 09 Vol. 31

CC-90010, a reversible, oral bromodomain and extra-terminal (BET) inhibitor in patients (Pts) with advanced solid tumours (STs) and relapsed/refractory (R/R) non-Hodgkin lymphoma: Updated results of a phase I study

Moreno, V., Braña, I., Sanchez, J.M. Sepulveda, Vieito, M., Hernández-Guerrero, T., Doger, B., Saavedra, O., Carlo-Stella, C., Michot, J-M., Italiano, A., Musuraca, G., Sarmiento, R., Amoroso, B., M
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.641
Date:
September, 2020
File:
PDF, 101 KB
2020
Conversion to is in progress
Conversion to is failed